McAllan, Liam
Baranasic, Damir http://orcid.org/0000-0001-5948-0932
Villicaña, Sergio http://orcid.org/0000-0002-2455-7095
Brown, Scarlett
Zhang, Weihua http://orcid.org/0000-0001-8279-3611
Lehne, Benjamin
Adamo, Marco
Jenkinson, Andrew
Elkalaawy, Mohamed http://orcid.org/0000-0002-0713-8198
Mohammadi, Borzoueh http://orcid.org/0000-0002-3194-4106
Hashemi, Majid
Fernandes, Nadia
Lambie, Nathalie
Williams, Richard
Christiansen, Colette http://orcid.org/0000-0001-6034-5746
Yang, Youwen
Zudina, Liudmila
Lagou, Vasiliki
Tan, Sili
Castillo-Fernandez, Juan
King, James W. D.
Soong, Richie http://orcid.org/0000-0002-0152-1225
Elliott, Paul http://orcid.org/0000-0002-7511-5684
Scott, James
Prokopenko, Inga http://orcid.org/0000-0003-1624-7457
Cebola, Inês http://orcid.org/0000-0003-3528-4982
Loh, Marie http://orcid.org/0000-0003-3626-8466
Lenhard, Boris http://orcid.org/0000-0002-1114-1509
Batterham, Rachel L. http://orcid.org/0000-0002-5477-8585
Bell, Jordana T. http://orcid.org/0000-0002-3858-5986
Chambers, John C.
Kooner, Jaspal S. http://orcid.org/0000-0003-2086-4837
Scott, William R. http://orcid.org/0000-0001-5467-114X
Funding for this research was provided by:
RCUK | Medical Research Council (MR/K002414/1)
Wellcome Trust (219602/Z/19/Z)
Article History
Received: 13 October 2021
Accepted: 3 May 2023
First Online: 15 May 2023
Competing interests
: R.L.B. participated in committees or advisory boards for ViiV Healthcare Ltd, Gila Therapeutics Ltd, Novo Nordisk, Pfizer, Eil Lilly, Royal College of Physicians, NHS England, National Institute for Health and Care Excellence, British Obesity and Metabolic Surgery Society, National Bariatric Surgery Registry, Association for the Study of Obesity, Obesity Health Alliance, International Federation for the Surgery for Obesity and Metabolic Diseases, Obesity Empowerment Network UK, and European Society for Endocrinology. R.L.B. has undertaken consultancy work for Novo Nordisk, Eli Lilly, ViiV Healthcare Ltf, Epitomee Medical Ltd. R.L.B. and participated in speakers’ bureaus for Novo Nordisk, Eli Lilly, ViiV HealthCare Ltd, Medscape and International Medical Press. The remaining authors declare no competing interests.